Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Steve Powers

Deutsche Bank · covers Consumer Defensive

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q3 (9 quarters).

Questions
101on tracked calls
Challenge rate
12%12 of 101 questions
Companies
22questioned at least once
Reporting periods
9with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 101 of 101 questions from 22 companies

MKCMcCormick & Company12 questions · 7 reporting periods · 2 of 12 challenging
MKC company page →

Calendar 2026 Q3

how confident are you that momentum can improve and be restored in that business before deal close?

ChallengingM&ADemandTranscript · FY2026 Q3 →
Show response

Foley said he cannot comment on Unilever Foods' trends but sees the same consumer pressures and no incremental concern for the deal thesis.

is there any further you can go in terms of, I guess, more discretely defining TSA scope

Show response

Gabriel said TSAs cover back-office support for about 2 years with a phased exit and costs already in the deal model; details to come.

Calendar 2026 Q2

for how long would you expect that to translate into what seems to be a favorable spread

Innovation & R&DDemandTranscript · FY2026 Q2 →
Show response

Foley framed the strength as aligned with durable consumer trends rather than a point-in-time benefit.

maybe you could shed a little bit more light, if you could, on the work that's going on behind the scenes

Show response

Foley described parallel, function-organized work streams hitting timelines, but deferred specifics to Q3.

Calendar 2026 Q1

could you speak at a high level to the scope anticipated duration of those agreements

Show response

Brendan said TSAs will cover IT system separation and first-year integration handover. Fernando added Unilever's food business is already more than 80% on external organization with own manufacturing, distribution, and salesforce, enabling separation without significant disruption.

Calendar 2025 Q3

is your kind of working assumption that there's a balance, kind of an even balance between pricing and some of the sourcing and savings initiatives

Cost PressurePricingTranscript · FY2025 Q3 →
Show response

Marcos confirmed 2026 mitigation is more skewed toward CCI savings, productivity, and alternative sourcing across all P&L lines. Pricing is the residual through surgical price initiatives.

what you've seen so far in early elasticity analytics and where you think consumers are likely to be more accepting of pricing

Show response

Brendan said it's too early for meaningful elasticity data with only about September available. Expressed confidence in analytics used to predict outcomes but acknowledged very limited real data so far.

Calendar 2025 Q2

does the incrementality of those distribution innovation pushes skew at all kind of 3Q versus 4Q?

Product LaunchRevenue GrowthTranscript · FY2025 Q2 →
Show response

Brendan expects even contribution from innovation/distribution across Q3 and Q4. Surgical pricing more likely in Q4. More new items hitting shelf in H2 vs H1. Distribution growth already appearing in data.

the decision to step down brand marketing. By my math, it looks like maybe a $5 million to $10 million reduction versus your prior planning

ChallengingCapex InvestmentCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Brendan said change reflects productivity/CCI efficiencies in A&P buying, not a strategy pullback. H2 still has significant year-over-year A&P increases. Continues to reinvest flexibly each quarter, did so in Q1 recipe mixes and Q2 hot sauce.

Calendar 2025 Q1

is there -- as we see net positive pricing flowing through your business this quarter and over the course of the year, as expected, is that -- is what we're really seeing

PricingCost PressureTranscript · FY2025 Q1 →
Show response

Brendan clarified EMEA pricing is targeted at specific commodity items like French desserts ingredients, not broad-based. Also focused on maintaining right price points on shelf alongside price gap management.

I was hoping you could talk a little bit more about what you're seeing in Europe and, I guess, in the EMEA segment as it relates to Consumer

MacroeconomicDemandTranscript · FY2025 Q1 →
Show response

Brendan noted European consumer trends closely mirror US, more scratch cooking, value-seeking, discounter growth, e-commerce acceleration. Inflation worry equally high in both regions.

Calendar 2024 Q4

on your brand marketing plans for the year. It sounded like the rates of increase year-over-year was going to be pretty even throughout the year

Capex InvestmentCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Marcos confirmed even cadence across quarters. Brendan added spend is allocated strategically across brands based on ROI, with some brands getting increased focus like Frank's RedHot receiving 12-month media coverage.

CHDChurch & Dwight10 questions · 7 reporting periods · 2 of 10 challenging
CHD company page →

Calendar 2026 Q2

do we see sort of a return to more of a full promotional stance in the back half as well?

Show response

Rick said consumption and organic are both around 5% with no disconnect, and a 2-year stack shows 5% in H1 and 6% in H2, expecting momentum to continue.

Calendar 2026 Q1

is there any heuristic you could offer as to how external dynamics—volatility in the Middle East, further increases or duration in oil—translate into that $25 million to $30 million growing

Cost PressurePricingTranscript · FY2026 Q1 →
Show response

CEO declined specific oil-to-cost heuristic. Laid out mitigation hierarchy: (1) productivity, (2) RGM on household promotions, (3) pricing behind innovation. Current $25-30M manageable; $50-100M+ would require escalation.

If it is transitory, is the productivity you are putting in place structural, or more belt-tightening such that, if it rolls over, some gets reinvested and some backfilled?

MarginCapital AllocationTranscript · FY2026 Q1 →
Show response

CEO clarified: not belt-tightening but acceleration of existing 3-year productivity pipeline. If costs reverse, could slow projects and reinvest savings into marketing to drive growth, 'build the virtuous cycle again.'

Calendar 2025 Q4

Are you just calling that out to kind of quantify it, make it a priority or -- and be more intentional about it?

Revenue GrowthProduct LaunchInnovation & R&DTranscript · FY2025 Q4 →
Show response

CEO confirmed ARM & HAMMER growth acceleration expected from 2026 onward with plans in place. TheraBreath paste targets loyal mouthwash following with best-in-class performance and superior flavor.

Calendar 2025 Q3

There's definitely a narrative about the Church & Dwight has been more promotional through the third quarter

ChallengingPricingCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

CEO pointed to amounts sold on deal as definitive metric showing CHD down YoY while competition up 300-600bps. Negative price/mix in laundry from larger size trade-up, not deeper discounting.

Calendar 2025 Q2

Just how do you think about your spending levels and your capabilities? How do you benchmark them against peers

Capex InvestmentInnovation & R&DTranscript · FY2025 Q2 →
Show response

CEO emphasized CHD's pay-as-you-go approach vs peers' restructuring programs. Investments in analytics CoE, pricing group, international infrastructure all embedded within Evergreen model.

can you talk a little bit about just how compartmentalized that business is and how easily separatable it is

Capital AllocationTranscript · FY2025 Q2 →
Show response

CEO described VMS as relatively compartmentalized with dedicated manufacturing in Vancouver and plant-within-plant in York. Some allocated costs would create stranded overhead, offset by Touchland addition.

Calendar 2025 Q1

what does success look like in terms of monitoring things as we go? And then ultimately, what is the I mean the expectation clearly the ambition is to be winning and growing

Product LaunchCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

CEO outlined KPIs: weekly POS inflection, customer reviews improvement, TDP stabilization, and confidence in growth from retrenched position.

the guidance implies -- I think your expectations are explicit about back half improvement in organic growth. And I'm just juxtaposing that against your expectation that you're not really expecting...

ChallengingRevenue GrowthGuidance ReliabilityTranscript · FY2025 Q1 →
Show response

CEO bridged to back half via: positive category growth returning, distribution gains, innovation, and sustained marketing investment.

Calendar 2024 Q4

just to kick the tires a little bit on the ERP upgrade that you called out in the release

Innovation & R&DMarginTranscript · FY2024 Q4 →
Show response

Dierker confirmed no revenue recognition impact in 2025, with SAP go-live pushed to Q1/Q2 2026. Linares highlighted BATISTE Sweat Activated (cross-category odor platform) and Hardball litter (open innovation with extruded sorghum) as examples of transformed R&D capabilities.

CLXClorox9 questions · 6 reporting periods · 0 of 9 challenging
CLX company page →

Calendar 2026 Q2

was there anything that was done differently in approaching the fiscal -- to fiscal '27 guidance formulation

Guidance ReliabilityTranscript · FY2026 Q4 →
Show response

Linda said FY2027 guidance used the same principled, factor-based approach as every year, with no extra conservatism for the transition.

Calendar 2026 Q1

can you just, Luc, maybe bridge exactly what's changed and what the drivers are between last quarter's full year outlook for gross margin down around 100 basis points and now down 250 to 300.

MarginGuidance ReliabilityTranscript · FY2026 Q3 →
Show response

Luc: Q4 GM ~5pts below year ago driven by: 150bps lapping ERP operating leverage (in prior outlook), 200bps GOJO (50bps ongoing + 150bps one-time inventory step-up), 100-150bps Middle East oil. Plus 50bps one-time cost savings acceleration investment. Net new vs prior outlook: GOJO + Middle East + some ERP cost overrun make up the ~150-200bps additional decline.

I'm assuming that annualized at $100, your impact at $100 of oil would be $80 million to $100 million.

Cost PressureDemandTranscript · FY2026 Q3 →
Show response

Linda cautioned against simple annualization, secondary/downstream effects from Middle East highly uncertain (Strait of Hormuz, infrastructure impacts). If only direct energy: $80-100M fair assumption but reality could differ materially. Luc on advertising: just rounding, GOJO brings Q4 down 1pt but only 25bps for full year, still rounds to 11%.

Calendar 2025 Q2

is there any potential risk of transition from an offsetting standpoint, I'm thinking, I guess, in some kind of structural period of essentially but would translate it like a destocking headwind.

Capex InvestmentInventoryTranscript · FY2025 Q4 →
Show response

Linda said no structural risk. ERP improves CLX internal efficiency and visibility but doesn't change retailer inventory processes. Retailers didn't hold extra inventory to compensate for old ERP. Benefits are cost removal on CLX side, not retailer behavior change.

is there any way -- any reason why from where we sit today that we shouldn't be thinking about kind of the midpoint of your normalized earnings exiting the year at around $7

Guidance ReliabilityMarginTranscript · FY2025 Q4 →
Show response

Luc confirmed: headline EPS midpoint + ~$0.90 ERP add-back = ~$7 normalized. Range exists around it given ERP and environment uncertainty.

Calendar 2025 Q1

Number one, why do you think that is? Because it's not just you had observed this as -- we've seen it in the outside

DemandMacroeconomicTranscript · FY2025 Q3 →
Show response

Linda said consumers have learned from prior cycles and trust branded essentials to work. Currently managing wallet through channel/size shifts, not category exit. Risk: uncertain how long volatility continues and whether deeper trade-offs force traditional trade-down. Watching closely.

Calendar 2024 Q4

I think as the year started, we had talked about free cash flow coming in around 12% of sales for the year. And at least that was our expectation. I think year-to-date, we're running closer to 9%.

Capital AllocationMarginTranscript · FY2025 Q2 →
Show response

Kevin said base FCF trending to high end of 11-13% target range. ERP will add $50-100M cash tie-up in Q4 (inventory build + prepaid suppliers), pulling reported FCF closer to 11%. All reverses in front half FY2026.

Is that a good number to kind of anchor to in terms of the cash cost that you're likely to have when that transition takes place?

M&ACapital AllocationTranscript · FY2025 Q2 →
Show response

Kevin confirmed ~$530M is the fair value anchor. Will repurchase P&G's 20% via cash or borrowing. Eliminating 20% cash flow payment currently in COGS will step up gross margin and earnings post-close.

Calendar 2024 Q3

just perspective on the Household penetration metric that you guys track, how that's progressing

DemandRevenue GrowthTranscript · FY2025 Q1 →
Show response

Linda said household penetration trend has reversed after pricing headwinds and cyber disruption. Back-half 3-5% is in line with consumption, not shipping ahead.

PGThe Procter & Gamble Company9 questions · 8 reporting periods · 2 of 9 challenging
PG company page →

Calendar 2026 Q2

how would you assess the underlying fundamentals of those markets as you think through the puts and takes?

DemandMacroeconomicInnovation & R&DTranscript · FY2026 Q4 →
Show response

Jejurikar quantified the market slowdown, sized the U.S. and Europe opportunity at $5 billion to $10 billion over 3 to 5 years, and said the innovation bar has to rise.

Calendar 2026 Q1

do you think productivity alone will be necessarily relied upon as offense to those factors?

Cost PressurePricingTranscript · FY2026 Q3 →
Show response

Andre acknowledged productivity alone likely insufficient to offset the full $1B after-tax headwind. Signaled selective pricing paired with innovation as the second offset lever.

in the third quarter, how do you assess underlying progress on organic growth?

Revenue GrowthDemandTranscript · FY2026 Q3 →
Show response

Andre expressed strong confidence in organic growth progress, citing breadth across regions and categories. Highlighted Tide liquid mid-teens growth and SK-II as evidence the model works.

Calendar 2025 Q4

on the second half, improvements, if we think about things by category segment versus by geography

Innovation & R&DCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Andre said family care grows in January, baby returning to global share growth; Shailesh said 12-18 months to fully distribute the reinvention.

Calendar 2025 Q3

Maybe just a little bit more perspective about what you've seen evolving on the ground in that market

Geographic ExpansionDemandTranscript · FY2026 Q1 →
Show response

Andre highlighted go-to-market/distributor changes, local innovation and communication upgrades as drivers of SK-II +12%, Baby Care +20% and Fabric Care +5 points.

Calendar 2025 Q2

could you elaborate further on those tailwind creation efforts and when within the fiscal year you might expect

Capital AllocationInnovation & R&DTranscript · FY2025 Q4 →
Show response

Jon highlighted Shailesh's Fabric & Home Care and COO experience; said tailwinds build over a planning-execution-impact cycle through the year.

Calendar 2025 Q1

has the nature of that investment changed at all? In terms of, you know, advertising versus trade or the like

Capex InvestmentInnovation & R&DTranscript · FY2025 Q3 →
Show response

Andre said media/advertising flat as % of sales; no shift between advertising and trade promotion.

Calendar 2024 Q4

I'm a little surprised that your currency outlook as it relates to the impacts on the top-line didn't move off

ChallengingFxPricingTranscript · FY2025 Q2 →
Show response

Andre confirmed spot rates, FX impact mostly H2, productivity levers and enterprise pricing offsets.

Calendar 2024 Q3

So what do you say to investors who are more concerned about deceleration from here in that underlying growth?

ChallengingDemandGuidance ReliabilityTranscript · FY2025 Q1 →
Show response

Andre pointed to the 85% developed-market core growing ~4% on high comps and easing headwinds as the basis for confidence.

KOThe Coca-Cola Company7 questions · 7 reporting periods · 1 of 7 challenging
KO company page →

Calendar 2026 Q2

there's a bit more investment in price/mix than we had expected to generate that volume

ChallengingPricingGeographic ExpansionTranscript · FY2026 Q2 →
Show response

Braun unpacked the Asia Pacific profit decline into three roughly equal drivers rather than deflecting.

Calendar 2026 Q1

you mentioned that you were fairly well positioned despite the broader inflationary backdrop as you think about the year

Cost PressureTrade TariffsTranscript · FY2026 Q1 →
Show response

John acknowledged bottlers face more aluminum/PET exposure, described system-wide RGM and procurement playbook used for years on disruptions.

Calendar 2025 Q4

a few months ago, you talked about some steady, [ you expressed ] as light drizzle in the macro environment that seems to be trending worse for consumers

MacroeconomicGeographic ExpansionTranscript · FY2025 Q4 →
Show response

James said India, China, ASEAN and some European markets need to build back volume through the year. Mexico tax impact more front-loaded in Q1. May see more price early in year with better balance later.

Calendar 2025 Q3

entering September, you'd called out momentum that was trending a bit slower than expected in the third quarter

DemandMacroeconomicTranscript · FY2025 Q3 →
Show response

James attributed improvement to system doubling down on marketing, innovation, affordability and execution rather than macro improvement. Environment expected to remain similar.

Calendar 2025 Q2

how quickly do you expect a rebound in those markets? And if there are any other markets as you go into the back half

Geographic ExpansionDemandTranscript · FY2025 Q2 →
Show response

James flagged ASEAN as the most surprising weakness area. Mexico cycling easier Q3 comp with hundredth anniversary plans. India getting new refranchised bottler via Jubilant Group.

Calendar 2025 Q1

could you talk maybe about how you're leaning more into some of those local brands in the current environment

Competitive DynamicsMacroeconomicTranscript · FY2025 Q1 →
Show response

James emphasized local nature of business (860,000 US jobs, $58B GDP contribution) and reinforcing 'made in' messaging rather than switching to local brands.

Calendar 2024 Q4

Your outlook seems to imply some pretty strong underlying margin and profitability progress just net of the FX pressures and the higher tax rate

MarginCost PressureTranscript · FY2024 Q4 →
Show response

James cited marketing transformation producing productivity without reducing investment. John noted modest gross margin expansion expected.

PEPPepsiCo7 questions · 7 reporting periods · 2 of 7 challenging
PEP company page →

Calendar 2026 Q2

is it more about optimizing and scaling the efforts that you've already put in motion

Product LaunchDemandInnovation & R&DTranscript · FY2026 Q2 →
Show response

Laguarta said portfolio transformation and portion-control are executing well (scaling Naked, Doritos protein); away-from-home slowed in Q2 but is accelerating in Q3; affordability tweaks underway.

Calendar 2026 Q1

have you seen any meaningful change at all in competitive intensity, whether pricing promotions or on shelf behavior

ChallengingCompetitive DynamicsPricingCost PressureTranscript · FY2026 Q1 →
Show response

Ramon acknowledged competitive intensity will increase in summer but emphasized the multi-lever strategy beyond price, plus productivity advantages competitors may not have.

Calendar 2025 Q4

how you expect the energy portfolio to contribute to that segment's progress, just how material that is

Competitive DynamicsM&ARevenue GrowthTranscript · FY2025 Q4 →
Show response

Ramon highlighted combined CELSIUS/Alani Nu approaching 20% energy share; Alani Nu integration showing improving execution metrics with more distributor onboarding ahead; good collaboration with CELSIUS team.

Calendar 2025 Q3

Could you just give a little bit more detail on where the interventions are specifically

Cost PressureSupply ChainTranscript · FY2025 Q3 →
Show response

Ramon detailed manufacturing node closures, warehouse rationalization with automation, go-to-market labor rightsizing, and global capability center efficiencies. On One North America, testing in Texas with nuanced regional solutions planned rather than one-size-fits-all.

Calendar 2025 Q2

if there's a way to distill those initiatives down to maybe the top 1, 2 or 3 things that you would say are the most critical

DemandRevenue GrowthTranscript · FY2025 Q2 →
Show response

Ramon walked through food (category stabilization, subsegment improvement, Lay's/Tostitos relaunch) and beverage (cola share gains, Gatorade recovery, Propel growth) pillars, targeting low end of algo in next few quarters.

Calendar 2025 Q1

just decompose in a bit more detail just the drivers of the reduced full-year earnings outlook

Trade TariffsGuidance ReliabilityTranscript · FY2025 Q1 →
Show response

Jamie clearly broke down: tariffs (new news), heightened macro/consumer uncertainty (Consumer Confidence nosedived), and Frito subdued performance. Top-line solidly in band when normalizing for international calendar.

Calendar 2024 Q4

the comments you made today, Ramon, signal a change on that front such that pricing in Frito could potentially start to run negative

ChallengingPricingDemandTranscript · FY2024 Q4 →
Show response

Ramon firmly rejected negative pricing, instead describing surgical price-pack architecture with multiple count and price-point options to give consumers flexibility without diluting pricing.

Show 16 more companies
ELEstée Lauder Companies (The)6 questions · 6 reporting periods · 0 of 6 challenging
EL company page →

Calendar 2026 Q2

on what has improved since May that's allowed you to upgrade the fiscal '27 margin outlook

MarginGuidance ReliabilityTranscript · FY2026 Q4 →
Show response

CFO tied the upgrade to the FY26 beat, further SG&A optimization and continued PRGP savings ramping into FY28; acknowledged Makeup/Hair/Fragrance profitability upside.

Calendar 2025 Q4

talk about what you're seeing in that segment and how you see the progression of profitability

MarginCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Akhil noted Q2 makeup profitability temporarily impacted by returns taken on Q3 innovation. No structural reason makeup margins should differ materially from other categories. PRGP fixed cost rightsizing and sales acceleration with Double Wear launch expected to improve margins. Stephane added TikTok Shop, Sephora entry for MAC, and innovation acceleration (19% vs 16% target) mostly from makeup.

Calendar 2025 Q3

I'm curious as to what degree you think you still have opportunities to catch up and how that plays into future planning?

Competitive DynamicsGeographic ExpansionTranscript · FY2026 Q1 →
Show response

Stephane detailed global expansion: Amazon in U.S., Canada, Japan, U.K., Mexico. TikTok Shop as consumer recruitment ecosystem. MAC in Sephora. Shopify DTC partnership. 40 net new fragrance freestanding stores. Europe team rolling out more TOM FORD, Jo Malone, KILIAN distribution. New 4-region structure enabling faster deployment with sophisticated media targeting by age group and retailer.

Calendar 2025 Q2

I was hoping you could just maybe better decompose the gap between retail sales and shipments that you see entering fiscal '26

Supply ChainDemandTranscript · FY2025 Q4 →
Show response

Akhil confirmed inventory reduced in every major market. Travel retail inventory now aligned with forecasted demand. North America still has some gap due to retail environment. Net sales expected to track retail much more closely in FY2026. Greater disconnect anticipated in Q1 but narrowing throughout the year.

Calendar 2025 Q1

can you talk about whether you expect that to be true kind of across all categories and geographies or whether you see outliers

Supply ChainDemandTranscript · FY2025 Q3 →
Show response

Akhil confirmed travel retail inventory significantly improved since December. North America retailers tightening inventories, reflected in outlook. Broader range given for Q4 due to volatility.

Calendar 2024 Q3

just amidst all this volatility, you get some perspective on how you see your market share standing across key markets

Competitive DynamicsDemandTranscript · FY2025 Q1 →
Show response

Tracey addressed regional outlook, noting continued China/TR pressure. Fabrizio detailed share gains in China skincare (+1pt), Japan fragrance (#1 position), and U.S. retail acceleration.

CLColgate-Palmolive5 questions · 5 reporting periods · 1 of 5 challenging
CL company page →

Calendar 2026 Q2

So I guess just in that context, perspective on your outlook and the expectations for Europe?

DemandGeographic ExpansionCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Noel credited Europe's success to a premium and super-premium toothpaste strategy shifted 3 or 4 years ago, now a template for North America.

Calendar 2025 Q3

to what extent are they really points of category acceleration or points of Colgate-specific differentiation versus more just the cost of doing business

ChallengingCloud & AIInnovation & R&DCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Wallace positioned initiatives as competitive advantage: faster innovation via AI, agentic commerce partnerships, demand planning automation. Sutula noted investments already well underway, not new costs.

Calendar 2025 Q2

when you think about doubling down and stepping up innovation capabilities, is it simply objective of more and more broad-based innovation

Innovation & R&DProduct LaunchTranscript · FY2025 Q2 →
Show response

Wallace highlighted need to improve breakthrough/transformational innovation. Will incubate more H2/H3 innovation with additional resources. Some geographies need faster H1 agility.

Calendar 2025 Q1

to what degree you will be carrying idle capacity on Hill's, you know, related to that into 2026

MarginCapex InvestmentGuidance ReliabilityTranscript · FY2025 Q1 →
Show response

Wallace noted network optimization absorbing freed capacity through share growth and SKU focus. Confirmed P&L flex exists, holding gross margin flat despite $200M tariffs demonstrates this.

Calendar 2024 Q4

how much of the expected underlying operating income improvement is going to be driven by that gross margin versus SG&A reductions

MarginCapex InvestmentCloud & AITranscript · FY2024 Q4 →
Show response

Wallace confirmed front-loaded capability investment in 2023-2024 provides solid base. Continued investment in data, technology, and AI planned. ROIC back to 35-36% as proof of discipline.

KHCKraft Heinz5 questions · 4 reporting periods · 1 of 5 challenging
KHC company page →

Calendar 2026 Q2

So just maybe a little bit more perspective on how you're seeing progression.

ChallengingCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Andre acknowledged share was flat Q2 versus Q1 as anticipated, tied partly to offsetting a 100 bps SNAP headwind, and pointed to ramping investment and innovation for improvement.

Calendar 2026 Q1

are you able to parse out where there is more meaningful, true underlying progress that you think can really be momentum you can build on versus maybe some transitory impacts

Revenue GrowthCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

CEO acknowledged Easter and weather tailwinds but cited share trajectory as genuine: total portfolio from 21% holding/gaining share to 58% in March. Taste Elevation from 24% to 87% in March. CFO added market share loss narrowed from -90 bps to -30 bps mix-adjusted.

anything to call out in terms of timing of year-to-go free cash flow

Capital AllocationMarginTranscript · FY2026 Q1 →
Show response

CFO noted H2 cash flow may decline due to investment step-up. Strong cash position enabling Q2 debt maturity paydown plus considering early repayment of portion of $1.9B maturing next year to reduce interest expense.

Calendar 2025 Q4

what how do we define short term? Is that know, do we need to see results, you know, in the next couple of quarters

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

CEO set timeline: exit 2026 with best trends during the year, target organic growth in 2027. Investments disproportionately U.S.-focused. No end date on separation pause; optionality preserved for future portfolio optimization.

Calendar 2025 Q3

are you able to frame maybe pro forma the performance of Global Taste Elevation Co. versus North American Grocery Co. in the third quarter

Show response

CFO disclosed both companies declining low single digits pro forma. Priority for Global Taste Elevation is return to growth in 2026. North American Grocery prioritizing stable cash flows. Declined to quantify one-time separation costs, citing ongoing work.

KMBKimberly-Clark4 questions · 4 reporting periods · 0 of 4 challenging
KMB company page →

Calendar 2026 Q2

greater confidence, maybe faster realization of the the existing $1.9 billion cost synergy target

M&ACapital AllocationTranscript · FY2026 Q2 →
Show response

Russ said the pace reflects greater confidence in achieving the outlined synergies rather than a higher number, with detailed cadence to come at deal close.

Calendar 2025 Q4

Just maybe a little bit more precision around how you expect the overall 2% category growth to shake out North America versus rest of world

Revenue GrowthMarginTranscript · FY2025 Q4 →
Show response

Urdaneta detailed net sales 50/50 first/second half with organic growth accelerating in back half. Productivity targeting ~6% again. Gross margin expansion of 70-80bps expected for 2026.

Calendar 2025 Q2

your overall assessment of competition, your pricing outlook for the balance of the year and any expectations or considerations

PricingCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Hsu confirmed PNOC discipline focus. Promotional intensity below category average and pre-COVID levels. Targeted pricing adjustments in some categories but promotion viewed as tactical trial lever only.

Calendar 2024 Q4

could you give us a bit more detail on the sources and timing of that productivity, your line-of-sight to achieving it cleanly

MarginCost PressureTranscript · FY2024 Q4 →
Show response

Urdaneta confirmed $200M SG&A savings ramping in 2025-2026. Hsu noted advertising spend at healthy 6.5% with plans to maintain similar level.

STZConstellation Brands4 questions · 3 reporting periods · 0 of 4 challenging
STZ company page →

Calendar 2026 Q3

is there a way to dimension maybe how you expect contributions to divide among them?

Revenue GrowthCompetitive DynamicsTranscript · FY2027 Q2 →
Show response

Fink declined to size contributions without mid-term guidance but cited Pacifico, Victoria and Mi CAMPO growth and runway for Modelo and Corona.

is there anything notable on your contracted or hedged on other operating costs that could be an advantage in 2027

Cost PressureMarginTranscript · FY2027 Q2 →
Show response

Hankinson said this year is hedged at or above 90% for most commodities and currencies, with hedges layered for later years, and Veracruz depreciation starts in fiscal 2028.

Calendar 2025 Q1

how you see the various factors stacking up to inform the flat to 3% outlook that you have on the portfolio you are planning to retain

DemandCapex InvestmentTranscript · FY2025 Q4 →
Show response

Bill cited Q4 retained wine depletion growth of 4% as evidence for premium-focused strategy. Garth said capacity expectations reduced through FY28 per slides, managing footprint responsibly.

Calendar 2024 Q4

my impression of Veracruz commitments is that they're a bit more fixed. So could you talk about whether that is correct or not

Capex InvestmentCapital AllocationTranscript · FY2025 Q3 →
Show response

Bill confirmed Veracruz on schedule but stressed future expansions at Veracruz or Obregon can speed up or slow down. Garth noted first Veracruz module is only 3M hectoliters.

BF-BBrown–Forman3 questions · 3 reporting periods · 0 of 3 challenging
BF-B company page →

Calendar 2026 Q2

I’m just wondering if there is a specific dollar amount in terms of that we should anchor to

MarginGuidance ReliabilityTranscript · FY2026 Q4 →
Show response

Peters set the organic operating income base at roughly $1.1 billion (reported ~$1 billion plus the impairment add-back) and confirmed a cash benefit as already-paid higher-cost inventory flows through the P&L, with working capital positive to cash flow.

Calendar 2026 Q1

you had mentioned in your opening remarks plans to. I think the word was liquidate aging barrels in the coming years. I just want to pause on that word. Liquidate.

Cost PressureSupply ChainTranscript · FY2026 Q3 →
Show response

Cunningham clarified 'liquidate' means emptying and bottling aged whiskey, not discounting. On taxes she said the lower rate reflects favorable year-over-year changes, lower state taxes and discrete items with a cash benefit, but expects a reversion to the normal 21% to 23% range going forward.

Calendar 2025 Q4

is it fair to assume that, that reverses, and that shipments and depletions end up the year essentially in line?

InventoryRevenue GrowthTranscript · FY2026 Q2 →
Show response

Leanne confirmed gap between shipments and depletions already narrowed significantly from Q1 to H1, expected to narrow further but shipments may remain slightly ahead due to continued Blackberry launch. Cautioned that New Mix will begin comping very strong prior year double-digit growth in H2. Declined to quantify distributor term benefits specifically but confirmed seeing flow-through.

HSYHershey Company (The)3 questions · 2 reporting periods · 0 of 3 challenging
HSY company page →

Calendar 2026 Q2

does that hold true as you look across performance maybe by income cohort.

DemandMacroeconomicTranscript · FY2026 Q2 →
Show response

Powers asked whether elasticities differ by income cohort; Kirk noted low-income households feel more pressure but balanced channel performance persists. Direct.

Calendar 2026 Q1

if perhaps that is a higher priority for incremental investment attention, then maybe on the outside, it's perceived

Innovation & R&DProduct LaunchTranscript · FY2026 Q1 →
Show response

Kirk confirmed functional snacking is a big growth area with double-digit growth currently. JV with VivaKi for breakthrough protein delivery. Small but mighty part of growth strategy.

I guess just want to frame how big that noncore part of the portfolio is today and whether that is something that we should keep in mind

Revenue GrowthCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Kirk confirmed private label will continue as a drag. Focus is on branded growth from Dots, Skinny Pop and LesserEvil which are driving exceptional growth in salty category.

KDPKeurig Dr Pepper3 questions · 3 reporting periods · 0 of 3 challenging
KDP company page →

Calendar 2025 Q4

One thing that I am left questioning, is the existing Keurig Dr Pepper Inc. debt. And how that is to be allocated across future bev versus CoffeeCo

Capital AllocationCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Anthony clarified capital structure: $9B new debt plus $5B JDEP rollover stays with CoffeeCo; existing KDP debt plus $4.5B convertible preferred stays with BevCo. Tim confirmed energy category expected to gain shelf space vs other LRBs with significant incremental distribution points especially in C-stores.

Calendar 2025 Q3

how do you get comfortable with the risk and opportunity costs of pursuing that and maintaining all the good that you've been doing

M&AGuidance ReliabilityTranscript · FY2025 Q3 →
Show response

Tim cited team's experience with large acquisitions and separations. TMO carved off dedicated team freeing rest of 29,000 employees to focus on base business. Q3 results as proof point.

Calendar 2024 Q4

I was hoping you could maybe building on what you outlined in your prepared marks around KDPs, ambitions and energy

Competitive DynamicsM&ATranscript · FY2024 Q4 →
Show response

Tim detailed energy portfolio strategy with complementary brands targeting distinct consumer cohorts. Set double-digit share goal. GHOST distribution transition starting in March.

KVUEKenvue3 questions · 3 reporting periods · 0 of 3 challenging
KVUE company page →

Calendar 2025 Q2

how big a headwind to organic growth would that be as you reduce the complexity and kind of cut the tail on complexity

Revenue GrowthCost PressureTranscript · FY2025 Q2 →
Show response

CFO deferred specifics on growth headwinds and restructuring costs as premature until strategic review progresses. Noted cash flow should remain in same neighborhood as prior year despite earnings decline.

Calendar 2025 Q1

whether today's change in some ways signals more appetite and more open-mindedness for analogous types of corporate action on Kenvue's part

Capital AllocationM&ATranscript · FY2025 Q1 →
Show response

CEO deflected the corporate action question by focusing on Amit's consumer goods expertise and profitable growth mandate. Did not address parallels to Kellogg/Kellanova separation.

Calendar 2024 Q4

how much progress do you think you'll be able to make against that 100% plus target in 2025

Capital AllocationCost PressureTranscript · FY2024 Q4 →
Show response

CFO explained 2024 free cash flow declined from $2.7B to $1.3B, split between separation costs and operational items. Not reaching 90-100% conversion in 2025 due to ongoing TSA/IT investment.

SJMJ.M. Smucker Company (The)3 questions · 3 reporting periods · 0 of 3 challenging
SJM company page →

Calendar 2026 Q3

maybe an update on how you're thinking about productivity and the -- maybe the pipeline that's building even as we look

MarginCost PressureTranscript · FY2027 Q1 →
Show response

Marshall affirmed continued transformation-office benefits but deferred specific productivity figures to future forums.

Calendar 2026 Q1

I just want to ask around the decision to start regularly amortizing the Hostess trademark beginning in the fourth quarter

Show response

Tucker explains: reduced long-term growth rate to 2% triggered reclassification from indefinite-lived to amortizable. Reflects prudent resource allocation approach. Full-year amortization outlook now $210M.

Calendar 2024 Q4

the sensitivity to demand has held pretty stable. You know, we were looking for things to potentially get worse quarter over quarter. And that doesn't seem to have happened

Show response

Mark explains Milk-Bone resilience across value spectrum. Innovation (PB Bites with Jif) performing exceptionally well. Pup-Peroni refresh planned. Not calling incremental softness.

GISGeneral Mills2 questions · 1 reporting period · 0 of 2 challenging
GIS company page →

Calendar 2025 Q4

Just anything to call out in terms of how much HMM impact is yet to come?

MarginSupply ChainTranscript · FY2026 Q2 →
Show response

Kofi outlined Q3 still down due to divestiture, investment, and trade timing drag; Q4 benefits from ~$100M trade expense timing tailwind plus 53rd week, together driving about 30% profit growth in Q4.

I guess I'm curious as to what degree you think Love Made Fresh has, in some ways, contributed to that base business progress

Product LaunchCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

CEO said too early to see Love Made Fresh halo effect on base Blue Buffalo; core improvement driven by sharpened LPF go-to-market, Tiki Cat growing solidly, and Tastefuls marketing plus pricing.

TAPMolson Coors Beverage Company2 questions · 2 reporting periods · 0 of 2 challenging
TAP company page →

Calendar 2026 Q2

how much of the expected improvement that you're calling for in the back half comes from identified cost savings

Cost PressureCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Rahul said EMEA/APAC top-line actions (Carling innovation, Madri, Above Premium) are already in motion, while the bottom-line improvement rests largely on cost savings and restructuring already actioned earlier in the year, plus U.K. Christmas-season timing.

Calendar 2025 Q3

Just curious as to exactly how the restructuring will enable that increased speed

Competitive DynamicsCapital AllocationTranscript · FY2025 Q3 →
Show response

Rahul said restructuring brings U.S. sales, marketing and Canadian leadership to the table for faster decision-making. Shifting resources regionally based on portfolio dynamics. Beer continues to get right marketing pressure on big brands; beyond beer gets balance sheet deployment. More detail to come on the exact balance.

CAGConagra Brands1 question · 1 reporting period · 0 of 1 challenging
CAG company page →

Calendar 2026 Q2

was there particular feedback that stood out or surprised you most?

Guidance ReliabilityTranscript · FY2026 Q4 →
Show response

Brase cited simplification and prioritization, restoring credibility by delivering on commitments, and the need to reinvest as the three top themes he acted on.

CELHCelsius Holdings, Inc.1 question · 1 reporting period · 0 of 1 challenging
CELH company page →

Calendar 2025 Q1

any kind of known headwinds that you would call-out in terms of reasons for sequential moderation in the gross margin

MarginCost PressureTranscript · FY2025 Q1 →
Show response

Langhans was comfortable with Q1 core margin but noted Alani inventory step-up noise and an uncertain H2, declining to draw a firm line on back-half margin.

CPBCampbell Soup Company1 question · 1 reporting period · 0 of 1 challenging
CPB company page →

Calendar 2026 Q3

if you had those 3 years ago, what decisions do you think you might have made differently

Innovation & R&DCompetitive DynamicsTranscript · FY2026 Q4 →
Show response

Beekhuizen said stronger consumer-insight and RGM capabilities would have made the company faster and better positioned, noting the growth office and RGM build (started six to nine months ago) are already bearing fruit in Campbell's RTS, condensed sauces and Goldfish gluten-free.

MNSTMonster Beverage1 question · 1 reporting period · 1 of 1 challenging
MNST company page →

Calendar 2025 Q2

case growth this quarter notably outpaced realized revenue growth, which obviously resulted in a lower all-in price per case

ChallengingPricingGeographic ExpansionTranscript · FY2025 Q2 →
Show response

CEO attributed lower price per case to geographic mix (41% international sales), product mix (faster Strategic Brands growth at lower price points), and increased affordable brand sales internationally.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
MKC McCormick & Company1217%2 of 12 questions
CHD Church & Dwight1020%2 of 10 questions
CLX Clorox90%none of 9 questions
PG The Procter & Gamble Company922%2 of 9 questions
KO The Coca-Cola Company714%1 of 7 questions
PEP PepsiCo729%2 of 7 questions
EL Estée Lauder Companies (The)60%none of 6 questions
CL Colgate-Palmolive520%1 of 5 questions
KHC Kraft Heinz520%1 of 5 questions
KMB Kimberly-Clark40%none of 4 questions
  • MKC
    McCormick & Company · 12 questions
    17%2 of 12 questions
  • CHD
    Church & Dwight · 10 questions
    20%2 of 10 questions
  • CLX
    Clorox · 9 questions
    0%none of 9 questions
  • PG
    The Procter & Gamble Company · 9 questions
    22%2 of 9 questions
  • KO
    The Coca-Cola Company · 7 questions
    14%1 of 7 questions
  • PEP
    PepsiCo · 7 questions
    29%2 of 7 questions
  • EL
    Estée Lauder Companies (The) · 6 questions
    0%none of 6 questions
  • CL
    Colgate-Palmolive · 5 questions
    20%1 of 5 questions
  • KHC
    Kraft Heinz · 5 questions
    20%1 of 5 questions
  • KMB
    Kimberly-Clark · 4 questions
    0%none of 4 questions
Show all 22 companies
CompanyQuestionsChallenge rate
STZ Constellation Brands40%none of 4 questions
BF-B Brown–Forman30%none of 3 questions
HSY Hershey Company (The)30%none of 3 questions
KDP Keurig Dr Pepper30%none of 3 questions
KVUE Kenvue30%none of 3 questions
SJM J.M. Smucker Company (The)30%none of 3 questions
GIS General Mills2—Rate withheld: fewer than 3 questions
TAP Molson Coors Beverage Company2—Rate withheld: fewer than 3 questions
CAG Conagra Brands1—Rate withheld: fewer than 3 questions
CELH Celsius Holdings, Inc.1—Rate withheld: fewer than 3 questions
CPB Campbell Soup Company1—Rate withheld: fewer than 3 questions
MNST Monster Beverage1—Rate withheld: fewer than 3 questions
  • STZ
    Constellation Brands · 4 questions
    0%none of 4 questions
  • BF-B
    Brown–Forman · 3 questions
    0%none of 3 questions
  • HSY
    Hershey Company (The) · 3 questions
    0%none of 3 questions
  • KDP
    Keurig Dr Pepper · 3 questions
    0%none of 3 questions
  • KVUE
    Kenvue · 3 questions
    0%none of 3 questions
  • SJM
    J.M. Smucker Company (The) · 3 questions
    0%none of 3 questions
  • GIS
    General Mills · 2 questions
    —rate withheld: under 3 questions
  • TAP
    Molson Coors Beverage Company · 2 questions
    —rate withheld: under 3 questions
  • CAG
    Conagra Brands · 1 question
    —rate withheld: under 3 questions
  • CELH
    Celsius Holdings, Inc. · 1 question
    —rate withheld: under 3 questions
  • CPB
    Campbell Soup Company · 1 question
    —rate withheld: under 3 questions
  • MNST
    Monster Beverage · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q3333%1 of 3 questions3
2024 Q41315%2 of 13 questions12
2025 Q1138%1 of 13 questions11
2025 Q21414%2 of 14 questions11
2025 Q31118%2 of 11 questions10
2025 Q4110%none of 11 questions10
2026 Q1157%1 of 15 questions10
2026 Q21513%2 of 15 questions14
2026 Q3617%1 of 6 questions4
  1. 2024 Q33 questions · challenge rate 33% (1 of 3 questions) · 3 companies
  2. 2024 Q413 questions · challenge rate 15% (2 of 13 questions) · 12 companies
  3. 2025 Q113 questions · challenge rate 8% (1 of 13 questions) · 11 companies
  4. 2025 Q214 questions · challenge rate 14% (2 of 14 questions) · 11 companies
  5. 2025 Q311 questions · challenge rate 18% (2 of 11 questions) · 10 companies
  6. 2025 Q411 questions · challenge rate 0% (none of 11 questions) · 10 companies
  7. 2026 Q115 questions · challenge rate 7% (1 of 15 questions) · 10 companies
  8. 2026 Q215 questions · challenge rate 13% (2 of 15 questions) · 14 companies
  9. 2026 Q36 questions · challenge rate 17% (1 of 6 questions) · 4 companies

Topics

Topics tagged on this analyst’s questions.

  • Competitive Dynamics25
  • Demand24
  • Margin20
  • Cost Pressure17
  • Revenue Growth14
  • Innovation & R&D13
  • Pricing13
  • M&A12
  • Capital Allocation12
  • Guidance Reliability11
Show all 19 topics
  • Capex Investment9
  • Macroeconomic7
  • Geographic Expansion7
  • Product Launch7
  • Supply Chain6
  • Inventory2
  • Trade Tariffs2
  • Cloud & AI2
  • Fx1